Skip to main content
. Author manuscript; available in PMC: 2010 Aug 27.
Published in final edited form as: Vaccine. 2009 Jul 17;27(39):5299–5306. doi: 10.1016/j.vaccine.2009.06.101

Figure 2. Epitope-based vaccine induces protective immunity to tularemia in HLA class II transgenic mice.

Figure 2

Groups of vaccinated and control mice were challenged i.t. with 2 LD50 (A) or 5 LD50 (B) F. tularensis LVS and survival was monitored over a 3-week period. Three experiments conducted under similar conditions yielded comparable results; the data derived from 2 of these experiments are shown.